TY - JOUR
T1 - Les cancers genitaux et mammaires feminins en France
T2 - Repartition geographique et estimation de l'incidence
AU - Chaplain, Gilles
AU - Grosclaude, Pascale
AU - Arveux, Patrick
AU - Raverdy, Nicole
AU - Menegoz, François
AU - Henry-Amar, Michel
AU - Schaffer, Paul
AU - Daures, Jean Pierre
AU - De Vathaire, Florent
PY - 1997/12/2
Y1 - 1997/12/2
N2 - The aim of the study was to assess the incident number of female breast and genital tract cancers for the whole of France. The study focused on the 1983-1987 period and on 9.1% of the French population. The incident number of female breast and genital tract cancers was estimated far each site and for each of eight French administrative regions covered by a cancer registry qualified through the National Committee of Registries (Calvados, Cote-d'Or, Doubs, Herault, Isere, Bas-Rhin, Somme, Tarn). Information on mortality rates was available at a regional level as well as at a nationwide level. The method estimated the national incidence rate modelizing the regional age- specific incidence rate as a function of corresponding mortality rate. Breast cancer was the leading site with 25,277 new cases per year while female genital tract cancers affected about 13,856 women. The cancer risk, estimated in using cumulative rate 0-74 years, was assessed at 7.1% for breast and at 1.2%, 1.4% and 1.1% for cervix uteri, corpus uteri and ovary respectively. Breast and genital tract cancers constituted 49% of the whole of cancers in women. Observed breast incidence rate was stable through French regions. There were pronounced contrasts in cervix uteri cancer risk, and some french regions displayed a high risk close to the observed European maxima. Interregional contrasts in risk of the other genital tract cancers were less striking. This study emphasized the importance of female breast and genital tract cancers for public health in France. The main aim of the French Cancer Registries Network is to provide a comprehensive description of cancer risk in France and to produce pertinent projection to 2005 horizon, combining the present data and the already accumulated 1988-1992 data.
AB - The aim of the study was to assess the incident number of female breast and genital tract cancers for the whole of France. The study focused on the 1983-1987 period and on 9.1% of the French population. The incident number of female breast and genital tract cancers was estimated far each site and for each of eight French administrative regions covered by a cancer registry qualified through the National Committee of Registries (Calvados, Cote-d'Or, Doubs, Herault, Isere, Bas-Rhin, Somme, Tarn). Information on mortality rates was available at a regional level as well as at a nationwide level. The method estimated the national incidence rate modelizing the regional age- specific incidence rate as a function of corresponding mortality rate. Breast cancer was the leading site with 25,277 new cases per year while female genital tract cancers affected about 13,856 women. The cancer risk, estimated in using cumulative rate 0-74 years, was assessed at 7.1% for breast and at 1.2%, 1.4% and 1.1% for cervix uteri, corpus uteri and ovary respectively. Breast and genital tract cancers constituted 49% of the whole of cancers in women. Observed breast incidence rate was stable through French regions. There were pronounced contrasts in cervix uteri cancer risk, and some french regions displayed a high risk close to the observed European maxima. Interregional contrasts in risk of the other genital tract cancers were less striking. This study emphasized the importance of female breast and genital tract cancers for public health in France. The main aim of the French Cancer Registries Network is to provide a comprehensive description of cancer risk in France and to produce pertinent projection to 2005 horizon, combining the present data and the already accumulated 1988-1992 data.
KW - Breast cancer incidence
KW - Cancer registry
KW - Female genital tract cancer incidence
UR - http://www.scopus.com/inward/record.url?scp=0030663642&partnerID=8YFLogxK
M3 - Article
C2 - 9435794
AN - SCOPUS:0030663642
SN - 0007-4551
VL - 84
SP - 935
EP - 940
JO - Bulletin du Cancer
JF - Bulletin du Cancer
IS - 10
ER -